Press Release

Funding for HIV Survives Extreme Cuts Proposed By House Republicans

Final FY24 Bill Includes Calls for HHS/CDC to Increase PrEP Access

21 March 2024 – PrEP4All, AVAC, HIVMA, and the PrEP in Black America coalition celebrate Congress’ decision to both fund domestic HIV programs at the same level as last year and to lift up calls for a National PrEP Program. The final 2024 Health and Human Services bill rejects extreme cuts to HIV funding proposed by House Republicans in July of last year. The organizations have led the charge on the #SaveHIVFunding campaign following efforts to eliminate $767M in critical funds to end HIV as an epidemic. We additionally thank House and Senate LHHS Appropriations Subcommittee leaders Senators Tammy Baldwin (D-WI) and Shelley Moore Capito (R-WV) and Representatives Robert Aderholt (R-AL) and Rosa DeLauro (D-CT) for working to ensure an effective and ultimately bipartisan outcome.

“Our movement for a National PrEP Program and to end HIV as an epidemic remains strong,” says PrEP4All Executive Director Jeremiah Johnson. “The final bill ultimately shows strong bipartisan support for HIV funding, including PrEP, and rejects the flawed effort by some House Republicans to zero out the Ending the HIV Epidemic Program. We created the #SaveHIVFunding campaign in collaboration with AVAC, HIVMA, and PrEP in Black America knowing that everyone in Congress needed to hear from community advocates in order to be successful in fighting these unnecessary deep cuts. Without this work and the concerted and brilliant efforts of so many HIV organizations within the Federal AIDS Policy Partnership, this win would not have been possible.”

The outcome means that a previous $25M increase going toward CDC’s efforts to improve equitable PrEP access will be preserved, which is critical as advocates continue to engage with CDC on ways to establish a foundation for a National PrEP Program using existing funds. Congress also included final report language directing CDC to increase access to PrEP and cited previous calls from the Senate to establish the “building blocks of a national program to increase awareness of PrEP, increase access to PrEP medication, [and] laboratory services…”

“This outcome is a win for Black communities across the nation who are disproportionately impacted by HIV. Making life-saving treatment and prevention a reality for Black Americans is a possibility because of our relentless advocacy work to #SaveHIVFunding,” says Raniyah Copeland, Founding member of the PrEP in Black America Coalition and Founder of Equity Impact Solutions. 

“This has been a long process, and we are grateful to have an outcome that leaves us on firm footing to realize the vision of a National PrEP Program,” says Andrea Weddle of HIVMA. “However, the fight for FY25 is already upon us following this prolonged budget process; meaning that advocates will have to remain vigilant, fight to protect our existing funding, and continue to ensure a clear, immediate, and fully funded pathway toward equitable PrEP access.”

“This is very encouraging news for PrEP advocates, especially following the President’s reintroduction of his proposal for a National PrEP Program last week.” Explains John Meade, Senior Program Manager for Policy at AVAC . “Combined with HIV/AIDS housing advocates’ victory in achieving an FY24 funding increase, I am so proud of our movement and our ability to rally in the face of these threats.”

A National PrEP Program would be a cost effective means to achieve our national goal of Ending the HIV Epidemic by 2030. Pre-Exposure Prophylaxis (PrEP) is a 99% effective use of medication to prevent HIV. Unfortunately 64% of people who could benefit from PrEP do not have access to it. A new study shows that states with the highest PrEP coverage showed an annual percentage decrease in HIV diagnoses of 8% from 2012 – 2021. In contrast, states with low PrEP coverage increased 2% annually. A National PrEP Program will increase access among people who could benefit and address major disparities in access related to race, gender and geographic location.  “In the current political environment, this Congressional action is especially noteworthy. But we must never confuse this progress with success; our fights for funding, equity and impact in treating and preventing this epidemic must continue, and funding and implementing a national PrEP program at scale and with urgency remains a huge priority,” said Mitchell Warren, Executive Director of AVAC.

Read the full press release here.

Avac Event

AVAC in Conversation with NIAID’s Jeanne Marrazzo

The new director of National Institute of Allergy and Infectious Diseases (NIAID), Dr. Jeanne Marrazzo joined AVAC Executive Director in conversation.

The HIV Prevention Pipeline

This graphic shows currently available options for HIV prevention, newly approved and recommended treatment, and those in development.

Avac Event

Webinar: The multipurpose prevention role of condoms in the context of SRH/HIV linkages

The male and female latex condom is the single, most efficient, available technology to reduce the sexual transmission of HIV and prevent unintended pregnancy. The search for new preventive and treatment technologies such as pre-exposure prophylaxis (PrEP), HIV vaccines, microbicides and male hormonal contraceptives continue to make progress, but condoms will remain a key component of combination prevention strategies individuals can choose at different times in their lives to reduce their risks of sexual exposure to HIV and prevent unintended pregnancy.

The Department of Reproductive Health and Research (RHR) is pleased to convene this webinar exploring the multipurpose prevention role of condoms in the context of these SRH/HIV linkages.

Register here.

Avac Event

Breaking Regulatory Barriers for Greater Female Condom Access

A variety of safe and effective female condoms currently exist. However, regulatory hurdles limit new products from entering consumer markets. With the pipeline of new receptive-partner initiated condoms growing, advocates must understand how regulatory issues determine product introduction and approval in their country.

Join the National Female Condom Coalition June 3 at 11:00am EST to learn about:

  • Receptive partner-initiated condoms in development
  • Link between regulatory environment and female condom access
  • Current regulatory issues and obstacles
  • Unique advocacy opportunity to break barriers to existing female condoms and pave the way for emerging internal condoms

Panelists will include:

  • Mags Beksinska, Director, MatCH Research
  • Coco Jervis, Program Director, National Women’s Health Network
  • Jessica Terlikowski, Director of Prevention Technology Education, AIDS Foundation of Chicago & National Female Condom Coalition

Avac Event

Exploring the Pipeline: Lubes, Rings, Films, Fibers, and Shots 4 HIV Prevention

AIDS Foundation of Chicago’s Jim Pickett and Jessica Terlikowski, presented Project Ready, Set, PrEP Plus (RSP+), a webinar on the research and development pipeline of new HIV prevention tools. New forms of PrEP were discussed – from lubricants and gels to injections, films, fibers, rectal douches and rings.

Avac Event

Women and HIV Prevention Research: Designing, testing and marketing products to improve adherence

The fourth webinar in AVAC’s Research & Reality series, a year-long dialogue about prevention research and advocacy, this call provided a forum to learn about and discuss key issues around women and the HIV prevention agenda, including challenges around marketing of and adherence to new prevention options.

View the full webinar here.

Avac Event

Women Deliver: Third Global Conference

Over 7,000 participants from around the world, including government leaders, policy makers, healthcare professionals, NGO representatives, corporate leaders and global media outlets met in Kuala Lumpur for Women Deliver 2013 (WD2013) . Billed as the largest global event of the decade to focus on the health and empowerment of girls and women, Women Deliver 2013 was a global platform for ensuring that the health and rights of girls and women remain top priorities now, and for decades to come.

AVAC and many of its partners participating in and presented at the conference. A number of sessions are still available for viewing and some tools and resources remain relevant:

Women Deliver 2013 Roadmap: There was a wide range of great sessions planned for WD2013 (full program available here ), and we pulled together a roadmap of select sessions focused on HIV-related issues — see below.

Watch the Conference: Much of Women Deliver 2013 was webcast. Click here to see available sessions to view.

Partner Tools: A number of our partners have also created roadmaps for the conference: CHANGE , PATH, the International HIV/AIDS Alliance, CAMI and the International Partnership for Microbicides.

Graphics: Women Deliver logos and graphics are available as well.

Women Deliver 2013 Roadmap: Below please see a roadmap of selected sessions that highlight HIV-related issues and linkages.

Monday, May 27

  • Side-event: Global Forum on Cervical Cancer Prevention, (9:00-17:00), click here for more information
  • Side-event: HIV Treatment Optimization and Women’s Rights and Empowerment: Making the Connection, (14:00-17:00) Rooms 307, 308, 309

Tuesday, May 28

  • Side-event: Getting to FP2020: Evidence Gaps and Research Priorities, (7:00–8:30)
  • More Than Mothers: Upholding the Sexual and Reproductive Health and Rights of Women in the Global Plan, (11:30 – 13:00) Grand Ballroom 2
  • Health and Community Systems Strengthening: An Integrated Response to Improve the Sexual and Reproductive Health of Women Living with and Affected by HIV, (11:30 – 13:00) Conference Hall 1
  • Maximising Access to Treatment for Women and Girls: What Will It Take?, (14:45 – 16:15) Room 310
  • Female Condoms Are _______ Film Festival, (18:30-20:30) Exhibit Hall 2, Hospitality Suite 2

Wednesday, May 29

  • Sexual Health, Rights, and Staying Safe: Are Women at Higher Risk of HIV Getting the Best from Their Health Services?, (11:00 – 13:00) Room 310
  • Plenary Lunch: The Challenges and Benefits of Partnership, (1315 – 1430) Grand Ballroom 2
  • Claiming Our Rights to Sexual and Reproductive Health: How Political Commitments to End AIDS Can Drive Improvements in Women’s Sexual and Reproductive Health, (14:45 – 16:15) Room 307

Thursday, May 30

  • Multi-purpose Prevention Technologies for Girls and Women, (11:00 – 13:00) Room 402
  • Plenary Lunch: Twenty Years Ago… What’s Missing in the 1990’s Programmes of Action: Moving Forward from the MDGs, (13:15-14:45) Grand Ballroom 2
  • Sexuality and Fertility—Choices and Challenges for Women Living with or at Risk for HIV, (15:00 – 16:00) Room 401

Avac Event

Next Generation Condoms: European research and perpectives

The sixth webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on the next generation of male and female condoms being introduced to meet specific HIV prevention needs.

The most up-to-date and comprehensive field-wide estimates for HIV prevention and R&D globally.

In its 16th annual report, the Resource Tracking for HIV Prevention Research & Development Working Group documents research and development spending for the calendar year 2020 and analyzes funding trends spanning twenty years.